16:02 Dec 20
Lupin Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Lupin Ltd.
Industry Pharmaceuticals
16:02 Dec 20
Quality
84/100
High Financial Strength
Valuation
39/100
Mid Valuation
Technical
65/100
Technically Moderately Bullish
Strength
18
Weakness
2
Opportunity
1
Threats
1
98.11K
Market Cap (Cr)
37.36
PE Ratio
6.27
Price to Book Ratio
RSI
9.56 %
Net Profit Margin